What are the causes of loculated pleural effusion in patients with a history of infections, malignancies, or inflammatory conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Loculated Pleural Effusion

Loculated pleural effusions develop when excessive fibrin formation from inflammatory processes creates septations that divide the pleural space into multiple separate pockets of fluid, with the primary causes being parapneumonic effusions/empyema, malignancy, and any inflammatory condition that triggers changes in procoagulant and fibrinolytic activity. 1

Primary Etiologic Categories

Infectious/Parapneumonic Causes

  • Bacterial pneumonia is the most common infectious cause, with 36-57% of bacterial pneumonias developing parapneumonic effusions that can progress to loculation 2
  • The most frequent causative organisms include Streptococcus pneumoniae, Staphylococcus aureus, and β-hemolytic streptococci 3
  • Empyema represents the advanced stage where bacterial invasion and fibrin deposition create thick septations and loculations 3

Malignant Causes

  • Lung cancer is the most common malignancy causing loculated pleural effusion, followed by breast cancer 4, 5
  • Septations are present in approximately 60% of malignant pleural effusions, with 15% showing extensive adhesions that obstruct two-thirds or more of the thoracoscopic view 1
  • The extent of pleural adhesions in malignant effusions correlates with greater pleural tumor burden and shorter median survival 1

Inflammatory/Autoimmune Causes

  • Lupus erythematosus and rheumatoid disease can cause inflammatory pleural effusions that develop loculations 6
  • Tuberculosis is an important cause, particularly in endemic regions 6

Pathophysiologic Mechanism of Loculation Formation

The development follows a predictable three-stage progression 3:

  1. Exudative stage: Clear fluid accumulates with low white cell count, low LDH, physiological pH, and normal glucose 3

  2. Fibropurulent stage: Fibrin deposition occurs in the pleural space, leading to septation and loculation formation, with white cell counts increasing dramatically, LDH rising, protein exceeding 3 g/dL, pleural fluid pH falling below 7.20, and glucose dropping 3

  3. Organizational stage: Fibroblasts infiltrate and convert fibrin strands into thick, non-elastic membranes that prevent lung re-expansion 3

Key Distinguishing Features

Septated vs. Loculated Effusions

  • Septated effusions have fibrinous strands within the fluid but allow free flow of fluid within the pleural space 1
  • Loculated effusions are divided into multiple separate pockets that prevent complete drainage and limit lung re-expansion, potentially contraindicating pleurodesis 1

Clinical Implications by Etiology

Parapneumonic/Empyema

  • Loculated parapneumonic effusions are associated with longer hospital stays and more complicated courses than simple effusions 7
  • These require earlier chest tube drainage and often need adjunctive fibrinolytic therapy 7

Malignant Effusions

  • Loculation can prevent complete drainage and result in insufficient symptomatic relief even with indwelling pleural catheters 1
  • If the underlying lung is non-expandable due to loculations, pleurodesis will be ineffective 7

Common Pitfalls

  • Failing to recognize the progression: Septated effusions can become loculated over time if left untreated, but the presence of septations does not necessarily prevent free fluid flow initially 1
  • Underestimating inflammatory causes: Any condition causing excessive fibrin formation due to inflammatory-mediated changes in procoagulant and fibrinolytic activity can lead to loculation 1
  • Delayed intervention: The fibropurulent stage represents a critical window where intervention can prevent progression to the organizational stage with irreversible fibrosis 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Intrapleural Fibrinolytic Therapy in Loculated Pleural Effusions.

The Journal of the Association of Physicians of India, 2020

Guideline

Pathophysiology of Pleural Effusion in Pneumonia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pleural Effusion in Adults-Etiology, Diagnosis, and Treatment.

Deutsches Arzteblatt international, 2019

Research

Malignant Pleural Effusion: Presentation, Diagnosis, and Management.

The American journal of medicine, 2022

Research

Pleural effusions.

The Medical clinics of North America, 2011

Guideline

Treatment of Loculated Pleural Effusions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.